Side view of medical scientist in protective mask using microscope while studying dangerous coronavirus in laboratory

NHLBI COVID-19 Research Funding

The NHLBI supports various initiatives and research related to COVID-19 to help prevent, detect, treat, and improve patient outcomes.

Learn more about NHLBI's multi-pronged COVID-19 research strategy.

COVID-19 research funding opportunities

 

Title

Type

Expiration Date

Activity Code

Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

Notice of Special Interest (NOSI)

September 9, 2020

Same as parent award

Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

Notice of Special Interest (NOSI)

September 9, 2020

Same as parent award

Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials

Notice of Special Interest (NOSI)

October 6, 2020

It is strongly recommended that the parent activity code be one of the following: P01, R01, R33, R41, R42, R43, R44, U01, U24, U54, UH3, or UM1.

Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials

Notice of Special Interest (NOSI)

October 6, 2020

It is strongly recommended that the parent activity code be one of the following: P01, R01, R33, R41, R42, R43, R44, U01, U24, U54, UH3, or UM1.

Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials

Notice of Special Interest (NOSI)

October 6, 2020

It is strongly recommended that the parent activity code be one of the following: P01, R01, R33, R41, R42, R43, R44, U01, U24, U54, UH3, or UM1.

Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations

Notice of Special Interest (NOSI)

December 30, 2020

Same as parent award

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19

Notice of Special Interest (NOSI)

December 30, 2020

Same as parent award

Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19) Notice of Special Interest (NOSI) Expired August 22, 2020 Same as parent award

Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

Notice of Special Interest (NOSI)

Expired
August 8, 2020

Same as parent award

Emergency Awards: Radx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)

Request for Application (RFA)

Expired
August 8, 2020

U24

Observational Studies of COVID-19 – A Cohort of Cohorts

Research Opportunity Announcement (ROA)

Expired July 27, 2020

 

ACTIV Integration of Host-targeting Therapies for COVID19

Research Opportunity Announcement (ROA)

Expired May 15, 2020

 

Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

Notice of Special Interest (NOSI)

Expired May 15, 2020

 

Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

Notice of Special Interest (NOSI)

Expired May 15, 2020

 

Resources for COVID-19 research

Last Updated July 31, 2020